• Journal of Physiology & Pathology in Korean Medicine
• /
• v.25 no.5
• /
• pp.887-893
• /
• 2011

The purpose of this study was to investigate the wound healing effects of Danggwieumja (DG), which is commonly used for skin inflammation, skin wound, skin pruritus, and chronic hives etc. The 1.5 cm ${\times}$ 1.5 cm full-thickness skin wound was induced to two groups, DG (n=16) and Saline (n=16) group. The DG extract and Saline were orally administrated daily for 15 days after skin wound induction. Then, the body weight of rats and the congestion indices were daily measured for 15 days after skin wound induction. The wound contractions and epithelizations were also measured. The wound contractions were daily measured for 15 days after wound induction and wound epithelizations were measured for 8 days from day 7 after wound induction. For evaluating angiogenesis, the immunoreactivities of vWF and VEGF protein were measured immunohistochemistrically on day 15. In results, although the percentage increases in mean body weight of rats in the DG and Saline groups hve no significant differences, DG extract decreased the time of wound healing and congestion around wound, and improved wound contraction and epithelization. The contraction percentage of DG group was significantly increased on day 5 (P<0.05) and day 7 (P<0.01) than that of Saline group. DG group showed significant increase of wound epithelization on day 7 (P<0.05) as compared to Saline group. Moreover, DG extract reduced the inflammation of skin dermis and promoted the growth of vascular vessels of dermis by accelerating vascular endothelial growth factor (VEGF) protein. These results suggest that DG has the beneficial effects on skin incision wound and can be the suitable wound healing agent for various surgical wounds.

• Herbal Formula Science
• /
• v.24 no.4
• /
• pp.385-393
• /
• 2016

Objectives : This study describes the clinical study of one drug eruption patient caused by unknown drugs treated with Korean medicine and acupuncture. Methods : We studied the case of 48-year-old woman. For treatment, herbal-medicine and acupuncture were applied. The patient was treated with Yongdamsagantang and Danggwieumja, acupuncture at Hapgok(L14), Taechung(LR03), Gokji(LI11). Hyeolhae(SP10), Joksamni(ST36), Sameumgyo(SP6), moxa at Gwanwon(CV4). Results : After treatment, the symptoms of urticaria, rash, itching, dryness, scale, burning sensation and the feeling a chill were disappeared. Conclusions : This study suggests that Korean medicine and acupuncture treatments show effective on drug eruption caused by unknown drugs.

• The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology
• /
• v.36 no.1
• /
• pp.124-131
• /
• 2023

Objectives : The aim of this study is to report the improvement of symptoms in patients with systemic erythema multiforme through Korean medicine treatment. Methods : We treated 51 years old male patient who diagnosed with erythema multiforme for 15 days with acupuncture, herbal medicine, pharmacopucture, cupping therapy and Hwangryunhaedok-tang wet dressing therapy. We used two herbal medicine; Hwabanhaedok-tang for first 10 days and Danggwieumja for another 5 days. Improvement of symptoms was evaluated by Visual Analogue Scale(VAS) and photography of lesions. Results : Most of the erythema disappeared, leaving only pigmentation. Subjective symptoms of patients such as itching, hot flash, dryness were decreased from VAS 7 to VAS 1-2. Conclusions : We found that Korean medicine treatment including herbal medicine, acupuncture was effective in improving systemic acute erythema multiforme.

• Journal of Physiology & Pathology in Korean Medicine
• /
• v.21 no.5
• /
• pp.1210-1218
• /
• 2007

Recently Atopic Dermatitis(AD) is increasing along with allergic disease. At present, there is no infallible cure for AD. Then AD patients undergo great suffering. This study is carried out to see whether or not the administering Danggwieumja(DG) along with Samhwangseje-gamibang(SG} as a medicine for external aplication, is effective in treating atopic dermatitis. To examine the effectiveness of the above prescription, the author made an observation of diverse immune responses. through the model of NC/Nga atopic mice. Results provided evidence that the DG administration along with SG can be used as a treatment means to atopic dermatitis. The results are as follows: The extent of Clinical skin severities in 13 and 16 week old NC/Nga mice treated with DG and SG, were reduced by 50.9%, 53.9% respectively, compared to the control NC/Nga mice with no drug treatment. IgE, IL-4, IL-5, IL-6, IgM and IgG1 levels in the serum of the NC/Nga mice treated with DG and SG were significantly decreased compared to those of the untreated control mice. In contrary, to the $IFN-{\gamma}$ level, significantly increased. The spleen weight of the NC/Nga mice treated with DG and SG significantly decreased compared to those of the untreated control mice. CCR3 gene expression in the skin tissue of NC/Nga mice treated with DG and SG were highly decreased, and the IL-6 expression significantly decreased, and the $IFN-{\gamma}$ gene expression increased compared to those of the untreated control mice. Histological observation of the ear and dorsal skin tissue of the NC/Nga mice treated with DG and SG, showed that the extents of inflammation and infiltrated immune cells in the epidermal tissue and dermis, were highly reduced compared to those of the untreated control mice. In the model inducing COX-2 activity in RAW 264.7 cell, the denser DG became, the more COX-2 activity was inhibited, compared to those of the untreated control group. $IL-1{\beta}$, and $TNF-{\alpha}$, IL-6 gene expression in RAW 264.7 cell with DG, significantly decreased, compared to those of the untreated control group. According to the assessment of cell toxicity in L929 cell, the rate of cell multiplication increased by 3% in consistency to 100ppm of DG compared to the untreated control group and in more than the 200 ppm consistency, cell toxicity was occurred.